145 related articles for article (PubMed ID: 26989635)
1. ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients.
Shi M; He J
PeerJ; 2016; 4():e1804. PubMed ID: 26989635
[TBL] [Abstract][Full Text] [Related]
2. Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma.
Liu G; Dong C; Wang X; Hou G; Zheng Y; Xu H; Zhan X; Liu L
Oncotarget; 2017 Nov; 8(58):98360-98370. PubMed ID: 29228695
[TBL] [Abstract][Full Text] [Related]
3. Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer.
Sun X; Wang X; Feng W; Guo H; Tang C; Lu Y; Xiang X; Bao Y
Oncol Lett; 2017 Apr; 13(4):2089-2096. PubMed ID: 28454366
[TBL] [Abstract][Full Text] [Related]
4. Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis.
Bu L; Huang F; Li M; Peng Y; Wang H; Zhang M; Peng L; Liu L; Zhao Q
PeerJ; 2021; 9():e11430. PubMed ID: 34035992
[TBL] [Abstract][Full Text] [Related]
5. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a prognostic 9-gene signature for colorectal cancer.
Cui J; Guo F; Yu Y; Ma Z; Hong Y; Su J; Ge Y
Front Oncol; 2022; 12():1009698. PubMed ID: 36465397
[TBL] [Abstract][Full Text] [Related]
7. Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III Colorectal Cancer: A Retrospective Study in 1780 Patients.
Ren H; Bösch F; Pretzsch E; Jacob S; Westphalen CB; Walter Holch J; Werner J; Angele MK
Ann Surg; 2022 Nov; 276(5):897-904. PubMed ID: 35880752
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients.
Li J; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Deng Y
Cancer Manag Res; 2020; 12():3301-3310. PubMed ID: 32494194
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer.
An N; Shi X; Zhang Y; Lv N; Feng L; Di X; Han N; Wang G; Cheng S; Zhang K
PLoS One; 2015; 10(9):e0137171. PubMed ID: 26325386
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
Shi M; Xu G
BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
[TBL] [Abstract][Full Text] [Related]
12. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer.
Feng J; Wei Q; Yang M; Wang X; Liu B; Li J
Ann Transl Med; 2021 May; 9(9):747. PubMed ID: 34268360
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Gene Expression Regulation Through m
Zhou Z; Mo S; Gu R; Dai W; Zou X; Han L; Zhang L; Wang R; Cai G
Front Oncol; 2020; 10():572708. PubMed ID: 33102231
[TBL] [Abstract][Full Text] [Related]
17. Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer.
Lin XT; Wu QN; Qin S; Fan DJ; Lv MY; Chen X; Cai JW; Weng JR; Zou YF; Rong YM; Gao F
Front Genet; 2021; 12():755789. PubMed ID: 34899841
[No Abstract] [Full Text] [Related]
18. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.
Shi M; Beauchamp RD; Zhang B
PLoS One; 2012; 7(7):e41292. PubMed ID: 22844451
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Sun D; Chen J; Liu L; Zhao G; Dong P; Wu B; Wang J; Dong L
PeerJ; 2018; 6():e4942. PubMed ID: 29915691
[TBL] [Abstract][Full Text] [Related]
20. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
